Chugai Venture Fund

Chugai Venture Fund

Boston, Massachusettschugaiventurefund.com

Overview

Chugai Venture Fund is a pioneering investment firm focused on fostering innovation and driving transformative advances in the life sciences industry. As a subsidiary of Chugai Pharmaceutical Co., Ltd., they leverage their parent company's extensive expertise and global presence to identify promising start-ups and cutting-edge technologies. Their mission is to help entrepreneurs and visionary teams realize their breakthrough ideas and ultimately contribute to the betterment of healthcare and society. The firm seeks to invest in drug discovery targets, drug discovery technology, and digital technology companies based in the United States, Japan, and Europe.

Year Founded

2023

Portfolio Companies

5

Investments

CompanyDateStageLead
Ten63 TherapeuticsFeb 2026StrategicLead
Ten63 TherapeuticsFeb 2026StrategicLead
Dualitas TherapeuticsSep 2025Series ACo-investor
Leal TherapeuticsAug 2025Series ACo-investor
Stylus MedicineMay 2025Series A ExtensionCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.